by EmpathiCSubstanceS | Apr 21, 2022 | Alcoholism, Microdosing, Neuropathy, NN-Dimethyltryptamine, OCD, Pain, Parkinson's Disease, Psilocybin Magic Mushroom, Psychotropics, PTSD
Everything to know about the hallucinogenic “spirit molecule”—common side effects include seeing aliens and finally connecting with the universe. When Jonathan Bell first tried DMT, he was already well-acquainted with psychedelics—at 34, he had taken acid and used...
by EmpathiCSubstanceS | Apr 21, 2022 | Alcoholism, Iboga, Kambo, LSD, MDMA Sassafras Molly, Microdosing, Neuropathy, NN-Dimethyltryptamine, OCD, Parkinson's Disease, Psilocybin Magic Mushroom
Follow-up data from a Phase III trial is the latest to suggest that MDMA—also known as ecstasy—could improve mental health when combined with therapy. The study found that MDMA-assisted therapy was better than talk therapy alone in relieving the symptoms of patients...
by EmpathiCSubstanceS | Apr 20, 2022 | Cannabis Marijuana, DMT, Iboga, Kambo, LSD, MDMA Sassafras Molly, Microdosing, Neuropathy, NN-Dimethyltryptamine, OCD, Pain
The world of microdosing is a lot bigger than just LSD or mushrooms. Researchers and users explain dosages, effects, and risks. There’s no scientific definition of microdosing, but generally, it means taking 1/20th to 1/10th the usual dose of a drug. LSD and mushrooms...
by EmpathiCSubstanceS | Apr 20, 2022 | Microdosing, Neuropathy, NN-Dimethyltryptamine, OCD, Pain, Parkinson's Disease, Psilocybin Magic Mushroom, Psychotropics, PTSD
From Sir Paul McCartney to Joe Rogan, these celebrities all credit psychedelics with changing their lives. Scientific studies reveal what many cultures have known for thousands of years—psychedelic medicines hold the potential to heal the mind, body, and soul, and...
by EmpathiCSubstanceS | Feb 2, 2022 | Cannabis Marijuana, Iboga, Kambo, LSD, Microdosing, Neuropathy, NN-Dimethyltryptamine, Pain, Parkinson's Disease, Psilocybin Magic Mushroom, Psychotropics, PTSD, San Pedro Mescaline
This question can be approached from a number of different levels. At the lowest functionally relevant level, how do the hallucinogenic compounds themselves interact with a certain neurotransmitter receptor to alter neuronal activity? Then at the neuronal population...
by EmpathiCSubstanceS | Feb 2, 2022 | LSD, MDMA Sassafras Molly, Microdosing, Neuropathy, NN-Dimethyltryptamine, OCD, Pain, Parkinson's Disease
Drug-induced hallucinations are often discussed as if they can be entirely understood in terms of their chemical action in the brain. But the social role of hallucinogens varies greatly between cultures, and, conversely, culture has a large effect on hallucinogenic...
